Skip to content

Can you use Xiidra with glaucoma? Understanding the Safety and Co-management

4 min read

According to ophthalmology experts, many glaucoma patients also suffer from ocular surface disease, which includes chronic dry eye. Managing dry eye is crucial for comfort and treatment adherence, leading many to ask: Can you use Xiidra with glaucoma?

Quick Summary

This article explains how Xiidra is a safe and effective dry eye treatment for individuals with glaucoma. It details how the medications work differently and provides guidance on co-managing both conditions for optimal eye health and comfort.

Key Points

  • Xiidra is safe with glaucoma: The prescription dry eye treatment, Xiidra (lifitegrast), does not affect intraocular pressure and can be safely used by patients with glaucoma.

  • Glaucoma treatments often cause dry eye: Many topical glaucoma medications contain preservatives that can exacerbate or cause dry eye disease, making Xiidra a useful co-treatment.

  • Space out your eye drops: When using both Xiidra and a glaucoma medication, wait at least 10 to 15 minutes between applications to ensure each medication is absorbed correctly.

  • Xiidra does not lower eye pressure: While Xiidra treats inflammation associated with dry eye, it does not lower intraocular pressure, which is the goal of glaucoma medications.

  • Improve comfort and treatment adherence: By effectively treating dry eye, Xiidra can improve overall ocular comfort for glaucoma patients, potentially increasing their adherence to their glaucoma drop regimen.

  • Understand potential side effects: The most common side effects of Xiidra are mild, such as eye irritation or an unusual taste, and are not related to glaucoma management.

  • Remove contact lenses: Always remove contact lenses before applying Xiidra and wait 15 minutes before reinserting them.

In This Article

Understanding Xiidra and Glaucoma

Xiidra (lifitegrast) and glaucoma are two different ocular conditions managed by entirely different types of medications. A clear understanding of each is essential for patients with both diagnoses.

What Xiidra Treats

Xiidra is a prescription eye drop specifically approved to treat the signs and symptoms of dry eye disease (DED) in adults. The condition is often linked to inflammation caused by the immune system's T-cells. Xiidra's active ingredient, lifitegrast, works by blocking a protein on these T-cells, thereby reducing inflammation and improving tear production. Its primary goal is to alleviate symptoms such as dryness, itching, burning, and a gritty sensation.

What Glaucoma Treatment Addresses

Glaucoma is a serious eye disease characterized by damage to the optic nerve, often caused by abnormally high pressure inside the eye, known as intraocular pressure (IOP). Medications for glaucoma, such as prostaglandin analogues or ROCK inhibitors like Rhopressa (netarsudil), are designed to lower this pressure. They function differently than Xiidra, either by increasing the outflow of fluid from the eye or by decreasing fluid production.

The Overlap: Why Glaucoma Patients Develop Dry Eye

Dry eye is a very common co-morbidity for individuals with glaucoma. The prevalence of DED among glaucoma patients is significant for several reasons:

  • Preservatives in Glaucoma Drops: Many standard glaucoma eye drops contain preservatives, most commonly benzalkonium chloride (BAK), to maintain sterility. Over time, prolonged use of drops with BAK can damage the ocular surface and disrupt the tear film, leading to or worsening dry eye symptoms.
  • Chronic Nature of Both Conditions: Both glaucoma and dry eye are typically chronic, requiring long-term management. The daily, ongoing use of multiple eye drops for glaucoma can compound the inflammatory issues leading to DED.
  • Age-Related Factors: Both glaucoma and DED are more common with increasing age, meaning many older patients will be managing both conditions simultaneously.

Is Xiidra Safe for Use with Glaucoma?

Yes, experts confirm that it is safe to use Xiidra with glaucoma. Xiidra does not have any known contraindications related to glaucoma and does not affect intraocular pressure. In fact, it is frequently prescribed for glaucoma patients to address dry eye symptoms. In a clinical study focused on dry eye treatment in glaucoma patients, no worsening of intraocular pressure was observed in the treated group. By effectively treating the underlying inflammation of DED, Xiidra can significantly improve the comfort and ocular surface health of glaucoma patients, potentially improving their tolerability of their glaucoma drops.

Co-managing Xiidra and Glaucoma Medications

For patients with both glaucoma and DED, successful management involves coordinating the use of multiple eye drops. Here are key considerations for co-management:

  • Timing: A crucial aspect is staggering the application of different eye drops. A recommended practice is to wait at least 10 to 15 minutes between applications of different types of eye drops. This prevents one drop from washing out the other, ensuring each medication has enough time to absorb properly and work effectively.
  • Contact Lenses: As with many eye drops, Xiidra should not be used while wearing contact lenses. Patients should remove their lenses before applying Xiidra and wait at least 15 minutes before reinserting them.
  • Preservative-Free Options: For patients with severe DED, particularly that aggravated by glaucoma drops, physicians may switch their glaucoma medication to a preservative-free alternative if available.

Comparison of Xiidra and Glaucoma Medications

Feature Xiidra (lifitegrast) Glaucoma Eye Drops (e.g., Rhopressa)
Primary Purpose Treats dry eye disease by reducing inflammation. Lowers intraocular pressure to prevent optic nerve damage.
Mechanism of Action LFA-1 antagonist, blocks T-cell activation and inflammation. Varies by drug class (e.g., ROCK inhibitor), increases fluid outflow or decreases production.
Main Target The ocular surface (cornea and conjunctiva). The aqueous humor and drainage system.
Effect on IOP No effect on intraocular pressure. Directly lowers intraocular pressure.
Common Side Effects Eye irritation, unusual taste (dysgeusia), blurred vision. Eye redness, conjunctival hemorrhaging, irritation.
Dosage Schedule Typically twice a day. Varies, often once daily for some types.
Preservative Preservative-free formulation. Often contain preservatives (BAK), though preservative-free versions exist.

Potential Side Effects and Precautions

While Xiidra is generally well-tolerated, especially when used correctly, patients should be aware of potential side effects and precautions. The most common side effects are typically mild and temporary, including:

  • Eye irritation, discomfort, or blurred vision upon instillation.
  • An unusual or unpleasant taste sensation (dysgeusia).

Serious side effects are rare but can occur, such as an allergic reaction, which would necessitate immediate medical attention. Allergic reactions are the only official contraindication listed for Xiidra. Patients with a known hypersensitivity to any of the ingredients should avoid its use. Unlike certain steroid eye drops, Xiidra is not known to increase IOP. Patients with active eye infections may be advised to wait until the infection resolves before starting Xiidra.

Conclusion

In conclusion, yes, you can use Xiidra with glaucoma under the supervision of an ophthalmologist. Xiidra is a safe and effective treatment for the inflammatory dry eye disease that often accompanies glaucoma. It works on a different biological pathway and does not negatively impact the high intraocular pressure associated with glaucoma. By addressing dry eye symptoms, Xiidra can improve ocular comfort and tolerance for preservative-containing glaucoma medications, thereby aiding overall treatment adherence and quality of life for the patient. The key to success is careful coordination with your eye care professional to ensure proper timing and management of all medications.

Authoritative Outbound Link

For more detailed information on glaucoma and its treatments, visit the BrightFocus Foundation website at brightfocus.org/resource/glaucoma-treatments-in-2024/.

Frequently Asked Questions

Xiidra is not known to affect intraocular pressure (IOP). Its active ingredient, lifitegrast, treats dry eye disease by reducing inflammation and does not act on the fluid dynamics that govern IOP.

No, it is important to space out your eye drop applications. You should wait at least 10 to 15 minutes between using Xiidra and any other eye drops to prevent one medication from washing out the other.

Dry eye is common in glaucoma patients because many glaucoma eye drops contain preservatives, like benzalkonium chloride (BAK), that can damage the eye's surface over time and cause or worsen dry eye symptoms.

Using Xiidra can significantly improve ocular comfort by treating dry eye inflammation, making it easier for you to tolerate your glaucoma medication. This can lead to better adherence to your treatment regimen and an overall improvement in your quality of life.

There are no known contraindications specific to using Xiidra in patients with glaucoma. The primary contraindication for Xiidra is a known hypersensitivity or allergic reaction to its ingredients.

Xiidra is not known to have adverse drug interactions with glaucoma medications, especially since they work through different mechanisms and affect different aspects of ocular health. Proper spacing of drops is the main coordination requirement.

Yes, you should always inform your ophthalmologist or doctor about all your medical conditions and the medications you are using, including both Xiidra and your glaucoma treatment. This ensures they can provide coordinated and safe care.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.